Urology Supplements Market Size, Share, Trends Analysis 2024-2032
Urology Supplements Market Size, Share, Trends Analysis 2024-2032

Urology Supplements Market Share, Size, Trends, Industry Analysis Report, By Type (Multi-ingredient, Single-ingredient); By Application; By Formulation; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Apr-2024
  • Pages: 120
  • Format: PDF
  • Report ID: PM4858
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

Urology supplements market size was valued at USD 2.13 billion in 2023. The market is anticipated to grow from USD 2.29 billion in 2024 to USD 4.16 billion by 2032, exhibiting the CAGR of 7.8% during the forecast period.

Market Overview

The urology supplements market includes a variety of products designed to support urinary tract health, prostate health, and overall urological well-being. These products may include dietary supplements, herbal remedies, vitamins, minerals, and other nutritional formulations specifically targeted toward addressing urological issues.

Urology supplements may target various demographic groups, including men, women, and seniors, depending on the specific urological condition being addressed. For example, supplements targeting prostate health are primarily marketed toward aging men, while products for urinary tract health may appeal to a broader demographic.

Urology supplements are witnessing a higher rate of demand with the rising kidney-related health issues in the global market. Urology deals with the functioning of the urinary tract, urinary bladder, kidney, ureters, and urethra. The increased accessibility to the healthcare infrastructure, coupled with growing government initiatives to promote healthcare services for several diseases, is fueling the demand for healthcare supplements. The strategic expansion initiatives among the market players are positively driving market growth.

Urology Supplements Market Size

To Understand More About this Research:Request a Free Sample Report

  • For instance, in January 2024, Sun Pharma joined forces with Bayer to distribute and market a chronic kidney medicine related to type 2 diabetes, Finerenone, in India under the brand name Lyvelsa.

Moreover, the rising number of healthcare providers and insurance companies showing interest in catering to kidney patients is optimally influencing the urology supplements market growth, as it enhances awareness about the disease and possible treatment opportunities for people. For instance, Strive Health, a provider of value-based kidney care, has announced a new partnership with insurer Medical Mutual, aimed at serving its 1.2 million members. Under this collaboration, Strive aims to offer its services to patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), regardless of whether they are covered under individual plans, Medicare Advantage, or commercial group health plans. The partnership, which commenced last summer, is expected to benefit a significant portion of Medical Mutual's member base. However, specific enrollment figures for the program have yet to be disclosed by Strive contribute to driving the urology supplements market.

Growth Drivers

  • Rising awareness of prostate cancer

The rising prevalence of prostate cancer among people is optimally influencing the urology supplements market growth in the foreseeable future. According to the American Cancer Society Report 2023, the incidence of prostate cancer is higher among black men compared to white men. The prevalence of prostate cancer has increased by 3% annually among the population between 2014 and 2019 in the United States. As a result, the urology supplements market is growing at a rapid pace in the global market.

  • Increase in the elderly population.

The elderly population is more likely to develop prostate cancer, driven by the increased chance of DNA cell damage over time. The growing geriatric population at the global level is driving the need for effective healthcare services and medications in the marketplace. According to the World Health Organization, 80% of older people will live in middle- and low-income countries by 2050. The higher chance of attaining urinary tract infections among the elderly population is creating critical requirements for urinary supplements. As a result, there will be significant growth and expansion activities for the global urology supplements market in the long run.

Restraining Factors

  • The emergence of cell and gene therapies is likely to impede market growth

The growing use of cell and gene therapeutics for the treatment of multiple diseases is likely to limit the use of urology supplements on the market, as they do not require oral tablets or liquid supplements. According to the research review published in the National Library of Medicine in 2023, 30% of kidney diseases can be treated by cell and gene therapies, primarily caused by monogenic diseases. As this gains more awareness in the global market, there will be a significant reduction in the demand for urology supplements in the long run.

Urology Supplements Market size

Report Segmentation

The market is primarily segmented based on type, application, formulation, distribution channel, and region.

By Type

By Application

By Formulation

By Distribution Channel

By Region

  • Multi-ingredient
  • Single-ingredient


  • Urinary Tract Infections
  • Kidney Health
  • Prostate Health
  • Bladder Health



  • Capsules
  • Softgels
  • Tablets
  • Liquid
  • Others



  • E-commerce
  • Brick & Mortar
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report:Speak to Analyst

By Type Analysis

  • Multi-ingredient segment is expected to witness the highest growth during the forecast period.

The multi-ingredient segment will grow rapidly due to its potential to cater to kidney-related problems efficiently with its combined capabilities. Women are 30% more likely to contract urinary tract infections. This is encouraging pharmaceutical companies to meet their health needs with the new supplement formulations. For instance, in May 2023, TruBiotics unveiled its new probiotic supplements for women to support their hair, skin, bone, urinary, and vaginal health. These supplements contain vitamins, minerals, and herbs. The rising development of multi-ingredient urology supplements is a major contributing factor to this segment's growth.

By Application Analysis

  • The urinary tract infections segment accounted for the largest market share in 2023.

In 2023, the urinary tract infections segment accounted for the largest market share. The increasing number of urinary tract infections is growing significantly with the sedentary lifestyle among the population. UTIs are one of the most common urological conditions globally, affecting millions of individuals each year. The high prevalence of UTIs contributes to a significant demand for urology supplements aimed at preventing and managing these infections. There has been increasing awareness among consumers about the importance of urinary tract health and the role of supplements in preventing UTIs. Many individuals, especially women, are proactively seeking out supplements containing ingredients known to support urinary tract health, such as cranberry extract or D-mannose.

By Distribution Channel Analysis

  • Brick & Mortar segment is anticipated to register significant growth over the forecast period.

The brick-and-mortar segment is expected to witness significant growth during the assessment period, driven by consumers' trust in medicines. The increasing number of kidney care companies expanding their presence is influencing the demand for brick-and-mortar centers. Furthermore, the ongoing initiatives by urology supplement providers are enhancing the availability of urology care supplements in wider retail networks.

Urology Supplements Market size

Regional Insights

  • North America region registered the largest share of the global market in 2023

In 2023, the North American region held the largest market share. This is due to the increased number of people witnessing kidney-related diseases. The developed countries, mainly the United States, are registering higher urology-based health problems, which is stimulating the demand for supplements. The Centers for Disease Control & Prevention reports that approximately 35.5 million people in the United States, or about 14% of US adults, are estimated to have Chronic Kidney Disease (CKD), which translates to more than 1 in 7 adults. Alarmingly, up to 9 in 10 adults with CKD are unaware of their condition, and about 1 in 3 adults with severe CKD remain undiagnosed. This lack of awareness regarding the disease is resulting in delayed diagnoses and deteriorating health outcomes.

APAC will grow at the fastest rate during the forecast period, owing to the growing need for healthcare services and the increasing geriatric population in the major countries, specifically India and China. Pharmaceutical companies' increasing product innovations and expansion initiatives are boosting market expansion.

Urology Supplements Market Size

Key Market Players & Competitive Insights

  • Strategic partnerships to drive the competition

The urology supplements market needs to be more cohesive. Market players are stepping forward with new research and development initiatives and product innovations around the world. The growing collaborative and partnership framework is positively driving the urology supplements market. For instance, in November 2023, One Biosciences entered a partnership with the Assistance Publique - Hôpitaux de Paris (AP-HP) to launch a single-cell research project on kidney disease.

Some of the major players operating in the global market include:

  • Biotexlife
  • Himalayan Organics
  • Himalaya Wellness
  • Natrol, LLC.
  • Nature's Bounty
  • Puritan's Pride
  • Schiff Nutrition           
  • Solaray
  • Theralogix

Recent Developments in the Industry

  • In October 2023, Sun Pharma and Zydus Lifesciences signed licensing agreement to market Desidustat, an oral medicine for treating anemia associated with chronic kidney disease.

Report Coverage

The urology supplements market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.

The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, type, application, formulation, distribution channel, and their futuristic growth opportunities.

Urology Supplements Market Report Scope

Report Attributes


Market size value in 2024

USD 2.29 billion

Revenue forecast in 2032

USD 4.16 billion


7.8% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments covered

  • By Type
  • By Application
  • By Formulation
  • By Distribution Channel
  • By Region

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Urology Supplements Market Share Analysis (2023)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel


Report customization as per your requirements with respect to countries, region and segmentation.


Urology Supplements Market report covering key segments are type, application, formulation, distribution channel, and region.

Urology Supplements Market Size Worth $ 4.16 Billion By 2032

Urology supplements market exhibiting the CAGR of 7.8% during the forecast period.

North America is leading the global market

the key driving factors in Urology Supplements Market are rising awareness of prostate cancer.